443
Views
10
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Hepatic hydrothorax: clinical review and update on consensus guidelines

, , , &
Pages 213-223 | Received 29 May 2016, Accepted 19 Aug 2016, Published online: 08 Sep 2016

References

  • Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med. 1958;49(1):193–203.
  • Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis. 1997;17(3):227–232.
  • Mouroux J, Perrin C, Venissac N, et al. Management of pleural effusion of cirrhotic origin. Chest. 1996;109(4):1093–1096.
  • Alberts WM, Salem AJ, Solomon DA, et al. Hepatic hydrothorax. Cause and management. Arch Intern Med. 1991;151(12):2383–2388.
  • Lazaridis KN, Frank JW, Krowka MJ, et al. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999;107(3):262–267.
  • Garcia N Jr, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol. 2004;38(1):52–58.
  • Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med. 2003;9(4):261–265.
  • Roussos A, Philippou N, Mantzaris GJ, et al. Hepatic hydrothorax: pathophysiology diagnosis and management. J Gastroenterol Hepatol. 2007;22(9):1388–1393.
  • Cardenas A, Arroyo V. Management of ascites and hepatic hydrothorax. Best Pract Res Clin Gastroenterol. 2007;21(1):55–75.
  • Krok KL, Cárdenas A. Hepatic hydrothorax. Semin Respir Crit Care Med. 2012;33(1):3–10.
  • Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20(3):271–279.
  • Lieberman FL, Hidemura R, Peters RL, et al. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med. 1966;64(2):341–351.
  • Alonso JC. Pleural effusion in liver disease. Semin Respir Crit Care Med. 2010;31(6):698–705.
  • Layden TJ, Kulik L. Hepatic manifestations of pulmonary diseases. Clin Liver Dis. 2002;6(4):969–979.
  • Jones EG. Hepatic hydrothorax: a retrospective case study. J Am Acad Nurse Pract. 2001;13(5):209–214.
  • Singh C, Sager JS. Pulmonary complications of cirrhosis. Med Clin North Am. 2009;93(4):871–883.
  • Kiafar C, Gilani N. Hepatic hydrothorax: current concepts of pathophysiology and treatment options. Ann Hepatol. 2008;7(4):313–320.
  • Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59(4):1627–1637.
  • Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine (Baltimore). 2014;93(3):135–142.
  • Johnston RF, Loo RV. Hepatic hydrothorax. Ann Intern Med. 1964;61:385–401.
  • Lieberman FL, Peters RL. Cirrhotic hydrothorax: further evidence that an acquired diaphragmatic defect is at fault. Arch Intern Med. 1970;125(1):114–117.
  • Esteve M, Xiol X, Ferna´dez F, et al. Treatment and outcome of hydrothorax in liver cirrhosis. J Clin Nutr Gastroenterol. 1986;1:139–144.
  • Giacobbe A, Facciorusso D, Barbano F, et al. Hepatic hydrothorax: diagnosis and management. Clin Nucl Med. 1996;21(1):56–60.
  • Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med. 1998;4(4):239–242.
  • Siddappa PK, Kar P. Hepatic hydrothorax. Trop Gastroenterol. 2009;30(3):135–141.
  • Xiol X, Castellote J, Baliellas C, et al. Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases. Hepatology. 1990;11(3):365–370.
  • Xiol X, Castellvı´ JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology. 1996;23(4):719–723.
  • Leuallen EC, Carr DT. Pleural effusion; a statistical study of 436 patients. N Engl J Med. 1955;252(3):79–83.
  • Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507–513.
  • Alagiakrishnan K, Patel PJ. Left-sided hepatic hydrothorax with ascites. Int J Clin Pract. 1999;53(3):225–226.
  • Giacobbe A, Facciorusso D, Barbano F, et al. Hepatic hydrothorax. Diagnosis and management. Clin Nucl Med. 1996;21(1):56–60.
  • Benet A, Vidal F, Toda R, et al. Diagnosis of hepatic hydrothorax in the absence of ascites by intraperitoneal injection of 99m-tc-fluor colloid. Postgrad Med J. 1992;68(796):153.
  • Gurung P, Goldblatt M, Huggins JT, et al. Pleural fluid analysis and radiographic, sonographic, and echocardiographic characteristics of hepatic hydrothorax. Chest. 2011;140(2):448–453.
  • Lieberman FL, Hidemura R, Peters RL, et al. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Inter Med. 1996;64(2):341–351.
  • John S, Paul MP, Murthy UK. An unusual presentation of cirrhotic pleural effusion in a patient with no ascites: a case report. Cases J. 2009;2:6767.
  • Kakizaki S, Katakai K, Yoshinaga T, et al. Hepatic hydrothorax in the absence of ascites. Liver. 1998;18(3):216–220.
  • Milanez De Campos JR, Andrade Filho LO, De Campos Werebe E, et al. Hepatic hydrothorax. Semin Respir Crit Care Med. 2001;22(6):665–674.
  • Zenda T, Miyamoto S, Murata S, et al. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol. 1998;93(11):2288–2289.
  • Emerson PA, Davies JH. Hydrothorax complicating ascites. Lancet. 1955;268(6862):487–488.
  • Chen A, Ho YS, Tu YC, et al. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol. 1988;10(6):663–666.
  • Kirschner PA. Porous diaphragm syndromes. Chest Surg Clin N Am. 1998;8(2):449–472.
  • Huang P-M, Chang Y-L, Yang C-Y, et al. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg. 2005;130(1):141–145.
  • Bhattacharya A, Mittal BR, Biswas T, et al. Radioisotope scintigraphy in the diagnosis of hepatic hydrothorax. J Gastroenterol Hepatol. 2001;16(3):317–321.
  • Holt KA, Oliviera E, Rohatgi PK. Hepatic hydrothorax demonstration by Tc 99m sulfur colloid ascites scan. Clin Nucl Med. 1999;24(8):609.
  • Rajnish A, Sudhakar P. Diagnosis of hepatic hydrothorax by Tc 99msulfurcolloidscintigraphy. Clin NuclMed. 2001;26(10):888.
  • Schuster DM, Mukundan S Jr, Small W, et al. The uses of diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax. Clin Nucl Med. 1998;23(1):16–18.
  • Benet A, Vidal F, Toda R, et al. Diagnosis of hepatic hydrothorax in the absence of ascites by intraperitoneal injection of 99m-tc-fluor colloid. Postgrad Med J. 1992;68(796):153.
  • Lee WJ, Kim HJ, Park JH, et al. Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis. Korean J Hepatol. 2011;17(4):292–298.
  • Kaplan LM, Epstein SK, Schwartz SL, et al. Clinical, echocardiographic, and hemodynamic evidence of cardiac tamponade caused by large pleural effusions. Am J Respir Crit Care Med. 1995;151(3 Pt 1):904–908.
  • Castellote J, Gornals J, Lopez C, et al. Acute tension hydrothorax: a life-threatening complication of cirrhosis. J Clin Gastroenterol. 2002;34(5):588–589.
  • Xiol X, Castellote J, Cortés-Beut R, et al. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med. 2001;111(1):67–69.
  • Kim JS, Kim CW, Nam HS, et al. Hepatic hydrothorax without ascites as the first sign of liver cirrhosis. Respirol Case Rep. 2015;4(1):16–18.
  • Baikati K, Le DL, Jabbour II, et al. Hepatic hydrothorax. Am J Ther. 2014;21(1):43–51.
  • Runyon BA. Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med. 1986;146(11):2259–2261.
  • Liu WL, Kuo PH, Ku SC, et al. Impact of therapeutic interventions on survival of patients with hepatic hydrothorax. J Formos Med Assoc. 2010;109(8):582–588.
  • Sawant P, Vashishtha C, Nasa M. Management of cardiopulmonary complications of cirrhosis. Int J Hepatol. 2011;2011:280569.
  • Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med. 2014;20(4):352–357.
  • Singh A, Bajwa A, Shujaat A. Evidence-based review of the management of hepatic hydrothorax. Respiration. 2013;86(2):155–173.
  • Romero-Candeira S, Hernández L. The separation of transudates and exudates with particular reference to the protein gradient. Curr Opin Pulm Med. 2004;10(4):294–298.
  • Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507–513.
  • Romero-Candeira S, Fernández C, Martín C, et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med. 2001;110(9):681–686.
  • Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117(3):215–220.
  • Castellote J, Xiol X, Cortes-Beut R, et al. Complications of thoracentesis in cirrhotic patients with pleural effusion. Rev Esp Enferm Dig. 2001;93(9):566–575.
  • McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31(2):164–171.
  • Schenk P, Fuhrmann V, Madl C, et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut. 2002;51(6):853–859.
  • Montanari M, Orsi P, Pugliano G. Hepatic hydrothorax without diaphragmatic defect. An original surgical treatment. J Cardiovasc Surg. 1996;37(4):425–427.
  • Sawabe J, Ishida H, Niizawa M, et al. Sonographic demonstration of diaphragmatic fistula in a patient with hepatic hydrothorax. Akita J Med. 1992;19:615–619.
  • Nakamura A, Kojima Y, Ohmi H, et al. Peritoneal–pleural communications in hepatic hydrothorax demonstrated by thoracoscopy. Chest. 1996;109(2):579–581.
  • Temes T, Davis MS, Follis FM, et al. Videothoracoscopic treatment of hepatic hydrothorax. Ann Thorac Surg. 1997;64(5):1468–1469.
  • Di Bisceglie MD, Paladini P, Voltolini L, et al. Videothoracoscopic obliteration of pleuroperitoneal fistula in continuous peritoneal dialysis. Ann Thorac Surg. 1996;62(5):1509–1510.
  • Stewart CA, Hung GL, Ackerman Z, et al. Radionuclide determination of peritoneo-pleural communication in hydrothorax. J Nucl Med. 1991;32:924.
  • Ellis G, Laurin J. Hepatic hydrothorax: diagnosis and management: case report and review of the literature. Md Med J. 1999;48(6):295–298.
  • Yaguchi T, Harada A, Sakakibara T, et al. A successful surgical repair of the hepatic hydrothorax using pneumoperitoneum: report of a case. Surg Today. 1999;29(8):795–798.
  • Williams MH. Pleural effusion produced by abdomino pleural communication in a patient with Laënnec’s cirrhosis of the liver and ascites. Ann Intern Med. 1950;33(1):216–221.
  • Streifler J, Pitlik S, Dux S, et al. Spontaneous bacterial pleuritis in a patient with cirrhosis. Respiration. 1984;46(4):382–385.
  • Chen TA, Lo GH, Lai KH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. J Chin Med Assoc. 2003;66(10):579–586.
  • Chen CH, Shih CM, Chou JW, et al. Outcome predictors of cirrhotic patients with spontaneous bacterial empyema. Liver Int. 2011;31(3):417–424.
  • Kirchmair R, Allerberger F, Bangerl I, et al. Spontaneous bacterial pleural empyema in liver cirrhosis. Dig Dis Sci. 1998;43(5):1129–1132.
  • Abba AA, Laajam MA, Zargar SA. Spontaneous neutrocytic hepatic hydrothorax without ascites. Respir Med. 1996;90(10):631–634.
  • Allam NA. Spontaneous bacterial empyema in liver cirrhosis: an underdiagnosed pleural complication. Saudi J Gastroenterol. 2008;14(1):43–45.
  • Tu CY, Chen CH. Spontaneous bacterial empyema. Curr Opin Pulm Med. 2012;18(4):355–358.
  • Castellote J, Lopez C, Gornals J, et al. Use of reagent strips for the rapid diagnosis of spontaneous bacterial empyema. J Clin Gastroenterol. 2005;39(4):278–281.
  • Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985;5(3):457–462.
  • Runyon BA, Akriviadis EA, Sattler FR, et al. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis. Dig Dis Sci. 1991;36(12):1782–1786.
  • Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403–409.
  • Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol. 1986;81(7):566–567.
  • Runyon BA, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39(3):841–856.
  • Schneider T, Reimer P, Storz K, et al. Recurrent pleural effusion: who benefits from a tunneled pleural catheter? Thorac Cardiovasc Surg. 2009;57(1):42–46.
  • Chalhoub M, Harris K, Castellano M, et al. Bourjeily. The use of the PleurX catheter in the management of non-malignant pleural effusions. Chronic Respir Dis. 2011;8(3):185–191.
  • Mercky P, Sakr L, Heyries L, et al. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration. 2010;80(4):348–352.
  • Shah R, Succony L, Gareeboo S. Use of tunneled pleural catheters for the management of refractory hepatic hydrothorax. BMJ Case Rep. 2011;2011. pii:bcr0520114213. doi:10.1136/bcr.05.2011.4213.
  • Degawa M, Hamasaki K, Yano K, et al. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt. J Gastroenterol. 1999;34(1):128–131.
  • Strauss RM, Martin LG, Kaufman SL, et al. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol. 1994;89(9):1520–1522.
  • Chalasani N, Gitlin N. TIPS for patients with refractory hepatic hydrothorax: what is the take home message? Am J Gastroenterol. 1997;92(11):2129–2130.
  • Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with TIPS. Hepatology. 1997;25(6):1366–1369.
  • Takayama T, Kurokawa Y, Kaiwa Y, et al. A new technique of thoracoscopic pleurodesis for refractory hepatic hydrothorax. Surg Endosc. 2004;18(1):140–143.
  • Ferrante D, Arguedas MR, Cerfolio RJ, et al. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97(12):3172–3175.
  • Ghandour E, Carter J, Feola M, et al. Management of hepatic hydrothorax with a peritoneovenous (Denver) shunt. South Med J. 1990;83(6):718–719.
  • Ikard RW, Sawyers JL. Persistent hepatic hydrothorax after peritoneovenous shunt. Asch Surg. 1980;115(9):1125–1127.
  • Luh S-P, Chen C-Y. Video-assisted thoracoscopic surgery (VATS) for the treatment of hepatic hydrothorax: report of twelve cases. J Zhejiang Univ Sci B. 2009;10(7):547–551.
  • Xiol X, Tremosa G, Castellote J, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int. 2005;18(6):672–675.
  • Sese E, Xiol X, Castellote J, et al. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol. 2003;36(1):75–77.
  • Ibrisim D, Cakaloglu Y, Akyuz F, et al. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient. Scand J Gastroenterol. 2006;41(7):862–865.
  • Kalambokis G, Fotopoulos A, Economou M, et al. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites. Nephrol Dial Transplant. 2005;20:2583.
  • Dumortier J, Lepetre J, Scalone O, et al. Successful treatment of hepatic hydrothorax with octreotide. Eur J Gastroenterol Hepatol. 2000;12(7):817–820.
  • Barreales M, Sáenz-López S, Igarzabal A, et al. Refractory hepatic hydrothorax: successful treatment with octreotide. Rev Esp Enferm Dig. 2005;97(11):830–835.
  • Sherman SC. Reexpansion pulmonary edema: a case report and review of the current literature. J Emerg Med. 2003;24(1):23–27.
  • Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest. 1987;91(6):817–822.
  • Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int. 2009;3(4):582–586.
  • Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology. 2000;118(1):138–144.
  • Siegerstetter V, Deibert P, Ochs A, et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13(5):529–534.
  • Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol. 2002;13(4):385–390.
  • Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis with transjugular intrahepatic portosystemic shunts. Gastroenterology. 1993;104:A941.
  • Salerno F, Cammà C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology. 2007;133(3):825–834.
  • Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27(6):742–747.
  • Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol. 2014;60(5):962–968.
  • Bethune N. Pleural poudrage: new technique for the deliberate production of pleural adhesion as preliminary to lobectomy. J Thorac Surg. 1935;4:251.
  • Colombo A, Boncinelli L, Pinzi M, et al. A new therapeutic approach in hepatic hydrothorax. Minerva Med. 1992;83(4):219–222.
  • Falchuk KR, Jacoby I, Colucci WS, et al. Tetracycline- induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment. Gastroenterology. 1977;72(2):319–321.
  • Lin CC, Wu JC, Chang SC, et al. Resolution of refractory hepatic hydrothorax after chemical pleurodesis with minocycline. Zhonghua Yi Xve Za Zhi (Taipei). 2000;63(9):704–709.
  • Goto T, Oyamada Y, Hamaguchi R, et al. Remission of hepatic hydrothorax after OK-432 pleurodesis. Ann Thorac Cardiovasc Surg. 2011;17(2):208–211.
  • Bielsa S, Hernandez P, Rodriguez-Panadero F, et al. Tumor type influences the effectiveness of pleurodesis in malignant effusions. Lung. 2011;189(2):151–155.
  • Saito R, Rai T, Saito H, et al. Two cases of intractable hepatic hydrothorax successfully treated with nasal CPAP. Nihon Shokakibyo Gakkai Zasshi. 2006;103(10):1146–1151.
  • Takahashi K, Chin K, Sumi K, et al. Resistant hepatic hydrothorax: a successful case with treatment by nCPAP. Respir Med. 2005;99(3):262–264.
  • Park SZ, Shrager JB, Allen MS, et al. Treatment of refractory nonmalignant hydrothorax with a pleurovenous shunt. Ann Thorac Surg. 1997;63(6):1777–1779.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.